Two Sigma Investments’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Two Sigma Investments’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,115	Closed	-$3.22K	–	3428
2024 Q2	$3.22K	Buy	+11,115	New	+$26.4K	﹤0.01%	2982
2023 Q3	–	Sell	-3,262	Closed	-$67.7K	–	3316
2023 Q2	$67.7K	Buy	+3,262	New	+$55.1K	﹤0.01%	2797
2023 Q1	–	Sell	-1,543	Closed	-$16.5K	–	3275
2022 Q4	$16.5K	Sell	1,543 -346	-18%	-$4.39K	﹤0.01%	2695
2022 Q3	$27K	Buy	+1,889	New	+$37K	﹤0.01%	2364
2022 Q1	–	Sell	-565	Closed	-$117K	–	4626
2021 Q4	$117K	Buy	+565	New	+$131K	﹤0.01%	4038

Other funds holding EFTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Two Sigma Investments's EFTR Position: Q3 2024 in Review

Two Sigma Investments sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2024, closing a stake of 11,115 shares — an estimated $3.22K sold.

Two Sigma Investments first reported a position in EFTR in Q4 2021 and held it in 5 quarters. The position peaked at $117K in Q4 2021. 3 funds tracked by Wall St. Rank hold EFTR as of Q3 2024.

Two Sigma Investments reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Two Sigma Investments sold 11,115 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $3.22K.
Two Sigma Investments first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
Two Sigma Investments's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $117K in Q4 2021.
3 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.